<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318966</url>
  </required_header>
  <id_info>
    <org_study_id>MCTW-GLY-03/14-18</org_study_id>
    <nct_id>NCT02318966</nct_id>
  </id_info>
  <brief_title>Glycosade v UCCS in the Dietary Management of Hepatic GSD</brief_title>
  <acronym>Glyde</acronym>
  <official_title>A Comparison of Glycosade® and Uncooked Cornstarch (UCCS) for the Dietary Management of Hepatic Glycogen Storage Diseases (GSD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vitaflo International, Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University College London Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Great Ormond Street Hospital for Children NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Necker-Enfants Malades</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vitaflo International, Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare efficacy of Glycosade® with uncooked corn starch (UCCS for the dietary management
      of hepatic glycogen storage diseases (GSD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      'Glyde' is a prospective, randomised, double-blind, crossover trial to compare the effects of
      two different starches used in the dietary management of GSD.

      The study will recruit 64 patients from six centres in the UK, USA, France and The
      Netherlands. The planned duration per participant is 2 years.

      Participants will be randomised into two equally sized groups:

      Arm A- Glycosade intake given first, followed by UCCS 1-6 weeks later Arm B- UCCS intake
      given first, followed by Glycosade 1-6 weeks later.

      The objective of this trial is to establish whether Glycosade® improves outcomes for patients
      with GSD compared to UCCS therapy by comparing the duration of normal blood sugars, lactate
      and ketone levels of patients with hepatic GSD (Types I, III, VI and IX) post equivalent
      intakes of UCCS and Glycosade®.

      The first part consists of two (blinded) 12 hour starch load tests administered randomly
      within a maximum 6 week period. Participants will be randomised to receive either UCCS or
      Glycosade® for the initial intervention period crossing over to the other product for the
      second intervention period (part 1).

      The second part (unblinded) is a 24 month open follow up whereby participant's will continue
      on the product considered most suitable by the clinician and patient.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 22, 2016</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess if Glycosade® will result in improved blood glucose, lactate and ketone levels in a larger group of patients with GSD I, III, VI &amp; IX as measured by duration of normal blood glucose levels or prevention of ketosis</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1. The insulin area under the curve during dietary management with UCCS compared to dietary management with Glycosade®.</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2. The area under the curve in lactate, BOHB, during dietary management with UCCS compared to dietary management with Glycosade®.</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Glycogen Storage Disease</condition>
  <arm_group>
    <arm_group_label>Glycosade</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be randomised to receive the medical food Glycosade as a starch load with a maximum dose of 100g. Glycosade to be taken as one dose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Uncooked corn starch</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will be randomised to receive uncooked corn starch as a starch load with a maximum dose of 100g. Uncooked corn starch to be taken as one dose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Medical Food - Glycosade</intervention_name>
    <description>double blind randomised crossover of 2 starches - glycosade and UCCS</description>
    <arm_group_label>Glycosade</arm_group_label>
    <arm_group_label>Uncooked corn starch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed by either genetic mutation analysis or enzymology study (this includes
             patients with only a single mutation but who also have supportive enzymology
             consistent with the condition). For those whom mutation analysis is not completed this
             will be assessed during the study.

          -  Aged 2 years or older (5 years or older in the USA)

          -  Established on full intake of uncooked corn starch therapy for at least 6 months

        Exclusion Criteria:

          -  Women who are pregnant or breastfeeding at the start of the study or planning to
             become pregnant during the study will be excluded.

          -  children less than 2 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helen Mundy, MRCP MRCPCH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guys and St Thomas NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karen McKittrick, MSc Nutr Med</last_name>
    <phone>+44 (0) 151 709 9020</phone>
    <phone_ext>207</phone_ext>
    <email>karen.mckittrick@vitaflo.co.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erika Brennan</last_name>
    <phone>+44 (0) 151 709 9020</phone>
    <phone_ext>323</phone_ext>
    <email>Erika.Brennan@Vitaflo.co.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Connecticut Children's Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Weinstein</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Antoine Béclère</name>
      <address>
        <city>Clamart</city>
        <zip>92140 Cedex</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurélie Hubert</last_name>
      <phone>+33 (01) 45 37 42 72</phone>
      <email>Aurelie.Hubert@Abc.Aphp.Fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Derks</last_name>
      <phone>+31 (0) 50 361 4156</phone>
      <email>T.G.J.Derks@UMCG.Nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Hospital for Neurology and Neurosurgery</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>WC1N 3BG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elaine Murphy</last_name>
      <phone>+44 (0) 203 448 4778</phone>
      <email>Elaine.Murphy@UCLH.NHS.UK</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evelina Children's Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helen Mundy</last_name>
      <phone>+44 (0) 207 188 0848</phone>
      <email>Helen.Mundy@GSTT.NHS.UK</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Great Ormond Street Hospital for Children</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Davison</last_name>
      <phone>+44 (0) 207 813 8549</phone>
      <email>James.Davison@GOSH.NHS.UK</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2014</study_first_submitted>
  <study_first_submitted_qc>December 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>February 12, 2018</last_update_submitted>
  <last_update_submitted_qc>February 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Glycogen Storage Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

